BobGengMD

PubMed

• Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis patients.
  Alexis Tracy, Lauren Loop, Safiyyah Bhatti, Christine Anterasian, Caitlyn Kellogg, Kathryn Smiley, Alyssa Wu, Bob Geng, Lawrence Eichenfield> ;Pediatric Dermatology. 2024 Jan 17
• Implementation of a pediatric synchronous multidisciplinary severe asthma clinic and real-world outcomes.
  Divya Patel, Michelle Dilley Revier, Anoushka Tambay, Bob Geng> ;Annals of Allergy, Asthma & Immunology. 2024 Mar 1
• 1 citations
  Rapid genome sequencing identifies novel variants in complement factor I.
  Katherine M Rodriguez, Jordan Vaught, Michelle Dilley, Kataryzna Ellsworth, Alaina Heinen, Yuzhou Zhang, Richard J H Smith, Robert Sheets, Bob Geng, Hal M Hoffman, H M...> ;Cold Spring Harbor Molecular Case Studies. 2022 Dec 1
• 1 citations
  A novel case of chronic spontaneous urticaria associated chronic myelogenous leukemia with rapid resolution upon treatment with imatinib.
  Alexis Tracy, Julia Kahn, Bob Geng, Marian Russo, Bijan Safai> ;JAAD Case Reports. 2022 Dec 1
• Allergen Content and Protease Activity in Milk Feeds from Mothers of Preterm Infants.
  Kathleen Luskin, Diba Mortazavi, Kerri Bertrand, Christina Chambers, Keriann Schulkers-Escalante, Alla Ahmad, Stephanie Luedtke, Anthony J O'Donoghue, Majid Ghassemian...> ;Breastfeeding Medicine. 2022 Nov 1
• 3 citations
  Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
  Roger H Kobayashi, Jiří Litzman, Isaac Melamed, J Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, T Prescott Atkinson, Syed Rehman, Sonja Höller, Eva Tu...> ;Clinical and Experimental Immunology. 2022 Dec 15
• 4 citations
  Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.
  Hannah Wangberg, Diba Mortazavi, Jessica Kitsen, Adepeju Sanni, Sydney Leibel, Bob Geng> ;Allergy and Asthma Proceedings. 2022 Sep 1
• 1 citations
  Mepolizumab prefilled syringe for the treatment of severe eosinophilic asthma: focus on the pediatric population.
  Michelle Dilley Revier, Bob Geng> ;Expert Review of Respiratory Medicine. 2022 Aug 1
• 7 citations
  Atopic dermatitisReview of comorbidities and therapeutics.
  Margaret M Appiah, Michael A Haft, Elana Kleinman, Jennifer Laborada, Stephanie Lee, Lauren Loop, Bob Geng, Lawrence F Eichenfield> ;Annals of Allergy, Asthma & Immunology. 2022 Aug 1
• 12 citations
  Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole.
  Michelle Dilley, Bob Geng> ;Clinical Reviews in Allergy & Immunology. 2022 Jun 1
• 19 citations
  A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.
  Evan S Dellon, Paneez Khoury, Amanda B Muir, Chris A Liacouras, Ekaterina Safroneeva, Dan Atkins, Margaret H Collins, Nirmala Gonsalves, Gary W Falk, Jonathan M Sperge...> ;Gastroenterology. 2022 Jul 1
• 5 citations
  A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.
  Evan S Dellon, Paneez Khoury, Amanda B Muir, Chris A Liacouras, Ekaterina Safroneeva, Dan Atkins, Margaret H Collins, Nirmala Gonsalves, Gary W Falk, Jonathan M Sperge...> ;The Journal of Allergy and Clinical Immunology. 2022 Jul 1
• 5 citations
  Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
  Bob Geng, Anne E Dixon, Jinnie Ko, Pranathi Janampally, Tmirah Haselkorn, Cecile T J Holweg, Thomas B Casale, Nizar Jarjour> ;Annals of Allergy, Asthma & Immunology. 2022 May 1
• 3 citations
  The impact of maternal asthma on the preterm infants' gut metabolome and microbiome (MAP study).
  Shiyu S Bai-Tong, Megan S Thoemmes, Kelly C Weldon, Diba Motazavi, Jessica Kitsen, Shalisa Hansen, Annalee Furst, Bob Geng, Se Jin Song, Jack A Gilbert, Lars Bode, Pie...> ;Scientific Reports. 2022 Apr 19
• 15 citations
  Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies.
  Bob Geng, Claus Bachert, William W Busse, Philippe Gevaert, Stella E Lee, Michael S Niederman, Zhen Chen, Xin Lu, Faisal A Khokhar, Upender Kapoor, Nami Pandit-Abid, J...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2022 Mar 1
• 2 citations
  Activated phosphoinositide 3-kinase δ syndrome associated with nephromegaly, growth hormone deficiency, bronchiectasis: a case report.
  Megan Craig, Bob Geng, Kristen Wigby, Susan A Phillips, Christine Bakhoum, John Naheedy, Mateja Cernelc-Kohan> ;Allergy, Asthma, and Clinical Immunology. 2022 Feb 21
• Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunode...
  Bob Geng, Kim Clark, Mark Evangelista, Eric Wolford> ;Frontiers in Immunology. 2022 Jan 1
• Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig]) in the treatment of patients with primary immu...
  Roger H Kobayashi, Sudhir Gupta, Isaac Melamed, J Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, Thomas Prescott Atkinson, Syed Rehman, Eva Turpel-Kant...> ;Frontiers in Immunology. 2022 Jan 1
• Balancing B cell responses to the allograft: implications for vaccination.
  Clarkson Crane, Lauren Loop, Christine Anterasian, Bob Geng, Elizabeth Ingulli> ;Frontiers in Immunology. 2022 Jan 1
• 5 citations
  Small molecule drugs for atopic dermatitis, rheumatoid arthritis, and hereditary angioedema.
  Bob Geng, Timothy J. Craig> ;Annals of Allergy, Asthma & Immunology. 2021 Oct 18
• Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
  Bob Geng, Adelaide A Hebert, Liza Takiya, Lauren Miller, John L Werth, Chuanbo Zang, Paul Sanders, Mark G Lebwohl> ;Dermatology and Therapy. 2021 Oct 1
• 3 citations
  Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
  Bob Geng, Adelaide A Hebert, Liza Takiya, Lauren Miller, John L Werth, Chuanbo Zang, Paul Sanders, Mark G Lebwohl> ;Dermatology and Therapy. 2021 Oct 1
• 9 citations
  Biologic Therapies for Allergic Rhinitis and Nasal Polyposis
  Bob Geng, Michelle Dilley, Christine Anterasian> ;Current Allergy and Asthma Reports. 2021 Jun 10
• 4 citations
  Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig® [octanorm]).
  Roger H. Kobayashi, Jose Fernando Mandujano, Syed M. Rehman, Ai Lan Kobayashi, Bob Geng, Thomas Prescott Atkinson, Isaac Melamed, Eva Turpel-Kantor, Elisabeth Clodi, S...> ;Immunotherapy. 2021 May 6
• 5 citations
  Primary immunodeficiency diseases treated with immunoglobulin and associated comorbidities.
  Michelle Dilley, Hannah Wangberg, Joshua M Noone, Bob Geng> ;Allergy and Asthma Proceedings. 2021 Jan 1
• Join now to see all